Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6MBC

Human Bfl-1 in complex with the designed peptide dF4

6MBC の概要
エントリーDOI10.2210/pdb6mbc/pdb
分子名称Bcl-2-related protein A1, dF4 (3 entities in total)
機能のキーワードanti-apoptotic bcl-2, inhibitor, design, apoptosis
由来する生物種Homo sapiens (Human)
詳細
タンパク質・核酸の鎖数2
化学式量合計20255.22
構造登録者
Jenson, J.M.,Keating, A.E. (登録日: 2018-08-29, 公開日: 2019-03-06, 最終更新日: 2024-10-23)
主引用文献Frappier, V.,Jenson, J.M.,Zhou, J.,Grigoryan, G.,Keating, A.E.
Tertiary Structural Motif Sequence Statistics Enable Facile Prediction and Design of Peptides that Bind Anti-apoptotic Bfl-1 and Mcl-1.
Structure, 27:606-617.e5, 2019
Cited by
PubMed Abstract: Understanding the relationship between protein sequence and structure well enough to design new proteins with desired functions is a longstanding goal in protein science. Here, we show that recurring tertiary structural motifs (TERMs) in the PDB provide rich information for protein-peptide interaction prediction and design. TERM statistics can be used to predict peptide binding energies for Bcl-2 family proteins as accurately as widely used structure-based tools. Furthermore, design using TERM energies (dTERMen) rapidly and reliably generates high-affinity peptide binders of anti-apoptotic proteins Bfl-1 and Mcl-1 with just 15%-38% sequence identity to any known native Bcl-2 family protein ligand. High-resolution structures of four designed peptides bound to their targets provide opportunities to analyze the strengths and limitations of the computational design method. Our results support dTERMen as a powerful approach that can complement existing tools for protein engineering.
PubMed: 30773399
DOI: 10.1016/j.str.2019.01.008
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.752 Å)
構造検証レポート
Validation report summary of 6mbc
検証レポート(詳細版)ダウンロードをダウンロード

237992

件を2025-06-25に公開中

PDB statisticsPDBj update infoContact PDBjnumon